Trial Profile
Expanded Access to B-Domain Deleted Recombinant Porcine Factor VIII (OBI-1) in the Treatment of Acquired Hemophilia A Due to Factor VIII Inhibitory Auto-antibodies
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Susoctocog alfa (Primary)
- Indications Haemophilia; Haemorrhage
- Focus Expanded access; Therapeutic Use
- Sponsors Shire
- 04 Nov 2013 New trial record